U.S. Food and Drug Administration News

Information on Nutrition and Medications

>

Multiple sclerosis patients have higher spinal fluid levels of suspicious immune molecule

Published in September 29th, 2008
Posted by Pharmaceutical News Feed in Drugs and Food Information, Pharmaceutical Industry News
Comments Off

A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.

continue reading.....

A control dashboard for the pharmaceuticals industry

Published in September 29th, 2008
Posted by Pharmaceutical News Feed in Drugs and Food Information, Pharmaceutical Industry News
Comments Off

Research scientists at SINTEF have developed a control dashboard for the pharmaceuticals industry. This enables all pharmacies, wholesalers and manufacturers to check where products are in the supply chain, availability, what stocks the neighbouring pharmacy has and the future prognoses.

continue reading.....

Improved Renal Function and Modest Hemodynamic Changes With Adenosine-Receptor Antagonist

Published in September 29th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off

The agent modestly reduced pulmonary capillary wedge pressures at the highest doses, had a weak diuretic effect, and improved renal-function measures. More research into the effects of A1-receptor antagonists on morbidity and mortality are still needed, say investigators.
Heartwire

continue reading.....

PAIS: No Overall Benefit of Acetaminophen (Paracetamol) After Acute Stroke

Published in September 29th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off

Results of a randomized trial have shown no overall benefit of treatment with acetaminophen after a stroke but hint at some benefit in those who have baseline body temperatures above 37°C.
Medscape Medical News

continue reading.....

Muscle Pain and Weakness With Statin Treatment May Herald ALS

Published in September 29th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off

In a new study, a high proportion of patients with sporadic amyotrophic lateral sclerosis who received statin therapy before diagnosis reported muscle weakness and pain related to statin treatment.
Medscape Medical News

continue reading.....

Liraglutide May Be Safe, Effective as First Drug Therapy for Type 2 Diabetes

Published in September 29th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off

A study shows that liraglutide leads to greater reductions in hemoglobin A1c levels, weight, hypoglycemia, and blood pressure vs glimepiride.
Medscape Medical News

continue reading.....

FDA Once Again Postpones Decision on Prasugrel

Published in September 29th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off

FDA continues its review of Prasugrel.
Heartwire

continue reading.....

On September 26th, FDA approves Alimta (pemetrexed) injection for use in combination with cisplatin therapy for the initial treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC).

Published in September 29th, 2008
Posted by FDA Center for Drug Evaluation and Research - What's New in Drug Evaluation and Research
Comments Off

On September 26th, FDA approves Alimta (pemetrexed) injection for use in combination with cisplatin therapy for the initial treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC). Prescribing Information

continue reading.....

Public Hearing for Over-the-Counter Cough and Cold Medications, October 2, 2008, Beltsville, Maryland

Published in September 29th, 2008
Posted by FDA Center for Drug Evaluation and Research - What's New in Drug Evaluation and Research
Comments Off

See Web site for updated information on this Public Hearing

continue reading.....

The FDA Has Now Spoken: Has the Time for First-line Fixed-dose Combination Therapy Arrived?

Published in September 29th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off

VALUE and ASCOT showed important benefits for treating hypertension early and intensively — in his video commentary Dr Black considers whether the FDA has drawn the appropriate conclusions.

Medscape Cardiology

continue reading.....

« Older Entries